HFA-PEFF Diagnostic Algorithm
Diagnostic algorithm for heart failure with preserved ejection fraction (HFpEF) using functional, morphological, and biomarker domains.
Laboratory Values
Comorbidities
History of atrial fibrillation
History of diabetes mellitus
History of hypertension
History of coronary artery disease
BMI ≥ 30 kg/m²
History of chronic obstructive pulmonary disease
History of sleep apnea
History of anemia
History of renal dysfunction
Scoring System
- EF 50-59%: 1 point
- EF ≥60%: 2 points
- Hypertension: 1 point
- Obesity (BMI ≥30): 1 point
- Atrial fibrillation: 1 point
- NT-proBNP 125-365 pg/mL: 1 point
- NT-proBNP ≥365 pg/mL: 2 points
- BNP 35-125 pg/mL: 1 point
- BNP ≥125 pg/mL: 2 points
- ≥5 points: HFpEF (high probability)
- 2-4 points: HFpEF (intermediate probability)
- 0-1 points: Unlikely HFpEF
HFA-PEFF Diagnostic Algorithm
The HFA-PEFF Diagnostic Algorithm is a validated diagnostic tool developed by the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) to diagnose heart failure with preserved ejection fraction (HFpEF). This algorithm uses a stepwise approach incorporating functional, morphological, and biomarker domains to improve diagnostic accuracy.
Algorithm Overview
The HFA-PEFF algorithm is designed to address the diagnostic challenges of HFpEF, which often presents with nonspecific symptoms and can be difficult to distinguish from other conditions. The algorithm uses a scoring system across three domains:
Scoring Domains
1. Functional Domain (0-2 points)
Based on left ventricular ejection fraction (LVEF):
LVEF | Points |
---|---|
50-59% | 1 |
≥60% | 2 |
2. Morphological Domain (0-2 points)
Based on structural and functional abnormalities:
Finding | Points |
---|---|
Hypertension | 1 |
Obesity (BMI ≥30 kg/m²) | 1 |
Atrial fibrillation | 1 |
3. Biomarker Domain (0-2 points)
Based on natriuretic peptide levels:
Biomarker | Level | Points |
---|---|---|
NT-proBNP | 125-365 pg/mL | 1 |
NT-proBNP | ≥365 pg/mL | 2 |
BNP | 35-125 pg/mL | 1 |
BNP | ≥125 pg/mL | 2 |
Diagnostic Classification
Total Score | Diagnosis | Probability | Clinical Implication |
---|---|---|---|
≥5 | HFpEF | High | Consider HFpEF-specific therapies |
2-4 | HFpEF | Intermediate | Consider additional testing |
0-1 | Unlikely HFpEF | Low | Consider alternative diagnoses |
Clinical Applications
The HFA-PEFF algorithm is used for:
- Diagnostic evaluation: Systematic assessment of patients with suspected HFpEF
- Risk stratification: Identifying patients at high probability of HFpEF
- Treatment decisions: Guiding therapeutic interventions
- Referral decisions: Determining need for specialist consultation
- Research inclusion: Standardizing patient selection for clinical trials
Management Recommendations by Probability
High Probability (Score ≥5)
- Diagnosis: HFpEF confirmed
- Management:
- Consider HFpEF-specific therapies
- Refer to heart failure specialist
- Optimize treatment of comorbidities
- Consider clinical trial enrollment
Intermediate Probability (Score 2-4)
- Diagnosis: HFpEF possible
- Management:
- Consider additional diagnostic testing
- Stress testing (exercise or pharmacological)
- Invasive hemodynamic assessment
- Advanced imaging (cardiac MRI, strain imaging)
- Close follow-up and reassessment
Low Probability (Score 0-1)
- Diagnosis: Unlikely HFpEF
- Management:
- Consider alternative diagnoses
- Reassess if symptoms persist
- Focus on treating underlying conditions
- Consider other causes of dyspnea
Important Considerations
The HFA-PEFF algorithm should be used as part of a comprehensive clinical assessment:
- Clinical context: Consider patient symptoms and presentation
- Comorbidities: Address underlying conditions that may contribute
- Dynamic assessment: Reassess as clinical status changes
- Individual factors: Consider patient-specific characteristics
- Limitations: Algorithm may not capture all cases
Validation and Performance
The HFA-PEFF algorithm has been validated in multiple studies:
- Sensitivity: Good for identifying HFpEF in appropriate populations
- Specificity: Helps distinguish HFpEF from other conditions
- Clinical utility: Improves diagnostic accuracy
- Reproducibility: Standardized approach to diagnosis
Advantages of the HFA-PEFF Algorithm
- Systematic: Structured approach to diagnosis
- Evidence-based: Developed from large clinical studies
- Practical: Uses readily available clinical data
- Comprehensive: Incorporates multiple diagnostic domains
- Standardized: Reduces diagnostic variability
Limitations and Considerations
The algorithm has several limitations:
- Not definitive: Should be used with clinical judgment
- Population-specific: May need adjustment for different populations
- Dynamic nature: Clinical status may change over time
- Resource-dependent: Requires access to echocardiography and biomarkers
- Comorbidity overlap: Many conditions share similar features
Integration with Clinical Practice
The HFA-PEFF algorithm should be integrated into clinical practice as follows:
- Use as part of a comprehensive clinical assessment
- Combine with other clinical parameters and judgment
- Consider patient preferences and values
- Regular reassessment as clinical status changes
- Follow institutional protocols and guidelines
- Use in shared decision-making with patients
Comparison with Other Diagnostic Approaches
The HFA-PEFF algorithm offers several advantages:
- More systematic: Compared to clinical judgment alone
- More comprehensive: Incorporates multiple domains
- More standardized: Reduces diagnostic variability
- More evidence-based: Developed from large clinical studies
- More practical: Uses readily available clinical data
The HFA-PEFF Diagnostic Algorithm is a valuable tool in the diagnosis of heart failure with preserved ejection fraction, providing clinicians with a systematic and evidence-based approach to improve diagnostic accuracy and guide management decisions.
References
- Pieske, B., Tschöpe, C., de Boer, R. A., Fraser, A. G., Anker, S. D., Donal, E., ... & Paulus, W. J. (2019). How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). European heart journal, 40(40), 3297-3317.
- Redfield, M. M., Borlaug, B. A., & Lewis, G. D. (2018). Heart failure with preserved ejection fraction: a review. JAMA, 320(1), 1-2.
- Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., ... & Westlake, C. (2017). 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Journal of the American College of Cardiology, 70(6), 776-803.
- Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G., Coats, A. J., ... & van der Meer, P. (2016). 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European heart journal, 37(27), 2129-2200.
Loading PDF...